CLASS II Drug recall · Reported 30 Jan 2019 · FDA Enforcement Report

Ezetimibe and Simvastatin Tablets 10mg/80 mg recalled

Dr. Reddy's Laboratories is recalling Ezetimibe and Simvastatin Tablets 10mg/80 mg, distributed nationwide in the US. The recall was initiated on 15 Jan 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 43E021 and 43E023, Exp. 01/2020
Quantity recalled118 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0389-2019
FDA event ID
81936
Recalling firm
Dr. Reddy's Laboratories, Princeton, NJ
Classification
Class II
Status
Terminated
Recall initiated
15 Jan 2019
FDA classified
22 Jan 2019
Reported
30 Jan 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

15 Jan 2019Recall initiated by company
22 Jan 2019Classified by FDA+7 days
30 Jan 2019Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Foreign Substance: Product complaint of black speckles observed on tablets.

Product as listed by the FDA

Ezetimibe and Simvastatin Tablets 10mg/80 mg, 1000-count bottles, Rx only, Manufactured by: Teva Pharmaceuticals Ind. Ltd. Jerusalem, 9777402, Israel; Distributed by: Dr. Reddy's Laboratories Inc. Princeton, NJ 08540 USA, NDC 43598-586-10

Where it was distributed

Nationwide within the United States

Nationwide

Questions about this recall

Why was it recalled?

Presence of Foreign Substance: Product complaint of black speckles observed on tablets.

Which lots are affected?

Lot #: 43E021 and 43E023, Exp. 01/2020

Where was it sold?

Nationwide within the United States

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Dr. Reddy's Laboratories

All 165

Other Ezetimibe recalls

All 10